Research Article

Canine Adipose Derived Mesenchymal Stem Cells Transcriptome Composition Alterations: A Step towards Standardizing Therapeutic

Table 2

Results of relative gene expression analysis. Summary of all results in different comparison set (CS).

GENE NAMECS1CS2CS3CS4CS5
All donorsY P3/Y P5O P3/O P5Y P3/O P3Y P5/O P5

ABCB1−3,70↓−12,09↓−2,70↓3,16
ACTA22,09
CEBPD−2,32↓
FGF102,23−3,05↓−2,50↓
JAG12,93
LPL−2,82↓−2,82↓−2,82↓3,753,02
NOTCH−2,05↓
SOX9−4,24↓−2,45↓
TBX5−2,19↓−2,3↓
BDNF2,10
BMP72,104,76−3,98↓
CSF3−2,65↓2,38
EGF−2,98↓
FUT12,152,55
GTF3A3,682,84
HGF−2,44↓2,10−68,91↓−16,6↓
IL63,164,592,154
KITLG−2,18↓
NES2,09−3,2↓
PTPRC−6,52↓
ALCAM−2,65↓
FZD9−2,36↓2,33
MCAM2,422,08
NGFR2,81
NT5E−2,06↓−3,98↓−6,29↓
VCAM1−5,37↓−9,5↓
VWF2,482,003,08
CASP3−2,11↓
POU5F13,97
SOX25,07
Total (%)7 (100)7 (100)15 (100)15 (100)16 (100)
Upregulated (%)5 (71,42)2 (28,57)10 (66,66)6 (40)6 (37,5)
Downregulated (%)2 (28,57)5 (71,42)5 (33,33)9 (60)10 (62,5)
Total (%)2 (28,57)2 (28,57)4 (26,6)6 (40)6 (37,5)

Differentiation markers2 (28,57)2 (28,57)4 (26,6)6 (40)6 (37,5)
MSCs associated markers (%)3 (42,8)4 (57,1)6 (40)5 (33,33)5 (31,2)
MSCs specific markers (%)2 (28,57)1 (14,28)3 (20)4 (26,6)5 (31,2)
Stemness markers (%)//2 (13,3)//

CS = comparison set, Y = young donor, O = old donor, and P = passage; numbers in italic and bold indicate fold regulation value.